Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity
DOI 10.1016/j.immuni.2005.06.008

Cited by (1,004)

Items 1,001–1,004 of 1,004

  1. Challenges and advances of the stability of mRNA delivery therapeutics
    J Zhai, T Cote, Y Chen · 2024 · Nucleic Acid Insights
  2. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
  3. Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial
    Cromer, Deborah, Reynaldi, Arnold, Steain, Megan, Triccas, James A, Davenport, Miles P, Khoury, David S · 2022 · Clinical Infectious Diseases
  4. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine
    Komori, Mai, Morey, Amber L., Quiñones-Molina, Andrés A., Fofana, Josiane, Romero, Luis, Peters, Elizabeth, Matsuda, Kenta, Gummuluru, Suryaram, Smith, Jonathan F., Akahata, Wataru et al. · 2023